ALZHEIMER’S DRUG DISCOVERY FOUNDATION: THERAPEUTICS FUNDING PROGRAMS-DRUG DEVELOPMENT 2025

Funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones.

Eligibility

• Academic medical centers and universities or nonprofits
• Biotechnology companies

The Therapeutics Funding Programs focus on three different RFP (Request for Proposal):

• Drug Development
• Neuroimaging and CSF Biomarker
• Prevention

Letter of intent deadline: September 15, 2025 5:00 pm ET

Invited full proposal: November 17, 2025 5:00 pm ET